Document is current
Any future updates will be listed below
-
Authors
Fusaroli, Michele https://orcid.org/0000-0002-0254-2212
Sartori, Daniele https://orcid.org/0000-0003-3634-0317
van Puijenbroek, Eugène P. https://orcid.org/0000-0002-2236-1398
Norén, G. Niklas https://orcid.org/0000-0002-4595-230X
- License Information
-
More Information
Article History
Received: 31 March 2025
Accepted: 11 August 2025
First Online: 24 September 2025
Declarations
:
: The authors declare no conflict of interest specific for this research. GNN and EvP are Editorial Board members of Drug Safety. GNN and EvP were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: Not applicable. This study did not use personal data.
: Not applicable. This study did not involve human participants.
: Not applicable.
: The data that support the findings of this study are not publicly available. Access to the data is restricted based on the conditions for access within the WHO Programme for International Drug Monitoring. Subject to these conditions, data are available from the authors on reasonable request. For further inquiries, please contact Uppsala Monitoring Centre via .
: The code used for this study is publicly available as a supplementary material and uses functions from the DiAna package []. Analyses were performed using R (version 4.4.2)
: MF, DS, GNN participated in the conceptualization and design of the study. MF performed the data analysis and the visualization and wrote the original draft. MF, DS, EvP, GNN contributed to the interpretation of results, and to the review and editing of the draft. All the authors read and approved the final version.
